linked in

IPS Technologies Tours at INTERPHEX 2014, February 2014

Read more...

 

Sam Halaby, Russ Somma, PhD, Mike Vileikis, Pharmaceutical Processing, Volume 29, Number 1, January/February 2014

Read more...

 

Pharmaceutical Processing, IPS Technologies Tours Supplement, April 2013

Read more...

 

Pharmaceutical Processing, March 2012, INTERPHEX 2012 Supplement

Read more...

 

Contract Pharma, October 2008


THE PHARMACEUTICAL INDUSTRY is buzzing about Quality by Design (QbD). To date, most contract manufacturers have stayed out of the discussion, assuming that the phrase has little to do with their role.
Read more...

ImagePharmAsia news, January 2008

Wyeth has acquired global rights to Mochida Pharmaceutical's preclinical transient receptor potential vanilloid sub-family 1 (TRPV-1) antagonist molecule for treating pain, the companies announced Jan 9. In retum , Tokyo-based Mochida will be paid developmental milestones, an up-front fee and royalties on future sales.
Read more...

ImageRuss Somma, Ph.D  - Journal of Pharmaceutical Innovation, December 2007

This article explores the processes used in developing a market formulation and requisite supportive data, particularly in light of the industry’s current movement toward submissions based on quality by design (QbD).
http://springerlink.com
Read more...

ImageRuss Somma, Ph.D  - Pharmaceutical Executive, November 2007

Approval letters delay NDAs, cost pharma plenty, and are at an all-time high.
Read more...